发明申请
- 专利标题： Human Anti-IP-10 Antibodies Uses Thereof
- 专利标题（中）： 人类抗IP-10抗体用途
-
申请号： US12529124申请日： 2008-02-28
-
公开(公告)号： US20100322941A1公开(公告)日： 2010-12-23
- 发明人: Nicolas Fischer , Marie Kosco-Vilbois , Olivier Leger
- 申请人： Nicolas Fischer , Marie Kosco-Vilbois , Olivier Leger
- 申请人地址： CH GENEVA
- 专利权人： NOVLMMUNE S.A.
- 当前专利权人： NOVLMMUNE S.A.
- 当前专利权人地址： CH GENEVA
- 国际申请： PCT/US08/02650 WO 20080228
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; C07K16/24 ; A61P37/02
摘要：
The invention relates to fully human antibodies, and fragments thereof, that bind to interferon-inducible-protein-10 (IP-IO, CXCL1O), thereby modulating the interaction between IP-IO and its receptor, CXCR3, and/or modulating the biological activities of IP-IO. The invention also relates to the use of such anti-IP-10 antibodies in the prevention or treatment of immune-related disorders and in the amelioration of one or more symptoms associated with an immune-related disorder.
公开/授权文献
- US08258267B2 Human anti-IP-10 antibodies uses thereof 公开/授权日：2012-09-04
信息查询
